FGF21 acts as a downstream metabolic target of oncogenes or as a corrective metabolic suppressor in tumor lesions (26, 27), with its overexpression antagonizing the development of liver and pancreatic cancers (28, 29). Here, FGF21 is linked to neoplasm.